Danimer Scientific (DNMR)
(Delayed Data from NYSE)
$0.33 USD
-0.06 (-15.52%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.38 +0.06 (16.92%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.33 USD
-0.06 (-15.52%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.38 +0.06 (16.92%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Zacks News
What Makes Danimer Scientific (DNMR) a New Buy Stock
by Zacks Equity Research
Danimer Scientific (DNMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Danimer Scientific, Inc. (DNMR) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Danimer Scientific (DNMR) delivered earnings and revenue surprises of 25% and 9.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Danimer Scientific, Inc. (DNMR) Report Negative Q1 Earnings? What You Should Know
by Zacks Equity Research
Danimer Scientific (DNMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Down -41.74% in 4 Weeks, Here's Why Danimer Scientific (DNMR) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Danimer Scientific (DNMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Danimer Scientific, Inc. (DNMR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Danimer Scientific (DNMR) delivered earnings and revenue surprises of 0% and 0.41%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Global Industrial (GIC) Q4 Earnings Match Estimates
by Zacks Equity Research
Global Industrial (GIC) delivered earnings and revenue surprises of 0% and 2.11%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Danimer Scientific, Inc. (DNMR) delivered earnings and revenue surprises of -14.71% and 23.44%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's How Energizer (ENR) Is Placed Ahead of Q4 Earnings
by Zacks Equity Research
Energizer's (ENR) fourth-quarter fiscal 2023 results are likely to reflect the impacts of soft consumer demand and weakness across its battery and auto care businesses.
Sociedad Quimica (SQM) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Sociedad Quimica's (SQM) third-quarter results are likely to have benefited from higher lithium and iodine volumes amid pricing headwinds.
Why Earnings Season Could Be Great for Danimer Scientific (DNMR)
by Zacks Equity Research
Danimer Scientific (DNMR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Karat Packaging (KRT) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Karat Packaging's (KRT) third-quarter 2023 earnings results are likely to reflect the benefits of its ongoing strategic initiatives, which are likely to have offset the impacts of lower revenues.
Danimer Scientific, Inc. (DNMR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Danimer Scientific, Inc. (DNMR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danimer Scientific (DNMR) Expands Partnership With CPChem
by Zacks Equity Research
Danimer Scientific (DNMR) and CPChem collaborate again to explore numerous high-volume polymer applications utilizing Rinnovo materials.
Danimer Scientific, Inc. (DNMR) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Danimer Scientific, Inc. (DNMR) delivered earnings and revenue surprises of -5.56% and 2.54%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
LegalZoom (LZ) Surges 5.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
LegalZoom (LZ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Danimer Scientific, Inc. (DNMR) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Danimer Scientific, Inc. (DNMR) delivered earnings and revenue surprises of -2.86% and 26.83%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
LegalZoom (LZ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
LegalZoom (LZ) delivered earnings and revenue surprises of 16.67% and 7.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
TPI Composites (TPIC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
TPI Composites (TPIC) delivered earnings and revenue surprises of -75.61% and 5.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Danimer Scientific, Inc. (DNMR) Q1 Earnings Expected to Decline
by Zacks Equity Research
Danimer Scientific, Inc. (DNMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danimer Scientific, Inc. (DNMR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Danimer Scientific, Inc. (DNMR) delivered earnings and revenue surprises of 6.67% and 8.68%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Danimer Scientific, Inc. (DNMR) delivered earnings and revenue surprises of -25% and 25.37%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Is iShares U.S. Infrastructure ETF (IFRA) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for IFRA
Should You Invest in the iShares U.S. Infrastructure ETF (IFRA)?
by Zacks Equity Research
Sector ETF report for IFRA
Are Options Traders Betting on a Big Move in Danimer (DNMR) Stock?
by Zacks Equity Research
Investors need to pay close attention to Danimer (DNMR) stock based on the movements in the options market lately.